Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-01-09Phase I Study of Whether Preclearance of Latent M. Tuberculosis (MTB) Infection With Isoniazid (INH) Enhances Specific Immune Responses to MTB Following Subsequent BCG Revaccination in Healthy, HIV-Uninfected, Tuberculin Skin Test Positive Adults
-
CLINICAL_TRIALS study record update · 2017-01-09Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis Vaccine (692342) When Administered to Healthy HIV-negative Adolescents Living in a TB Endemic Region
-
CLINICAL_TRIALS study record update · 2017-01-06Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine (692342) in HIV-positive Adults.
-
CLINICAL_TRIALS study record update · 2016-11-30Evaluation of the Heterologous Effects of Bacille Calmette-Guérin (BCG) Vaccination in Healthy UK Adults
-
CLINICAL_TRIALS study record update · 2016-11-18Pharmacokinetics and Safety of Moxifloxacin; a Dose Escalation in Patients With Tuberculosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-11-02Population Pharmacokinetic Analysis of Sulfamethoxazole and Trimethoprim in Normal Weight, Overweight, and Obese Volunteers
-
CLINICAL_TRIALS study record update · 2016-10-27Evaluation of Rapid Diagnostic Tests (RDT) in Association With Clinical and Laboratory Predictors for the Diagnosis of Neglected Tropical Diseases (NTD) in Patients Presenting With Persistent Fever (≥1 Week) in Cambodia, Nepal, Democratic Republic of the Congo and Sudan
-
CLINICAL_TRIALS study record update · 2016-10-06Diagnostic Evaluation of a Urine and Plasma Based LAM FLISA for the Diagnosis of Infection With Mycobacterium Tuberculosis
-
CLINICAL_TRIALS study record update · 2016-09-28A Phase 2 Randomized, Open-label Trial of Daily Rifapentine 450mg or 600mg in Place of Rifampicin 600mg for Intensive Phase Treatment of Smear-positive Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2016-09-23Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis in a North-American Tertiary Center at the Beginning of the 21st Century
-
CLINICAL_TRIALS study record update · 2016-08-16Converging Epidemics: Immunobiology of Diabetes Mellitus and Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2016-08-02A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose, Dose-Ranging Study of the Safety and Immunogenicity of DAR-901, a Killed, Non-Tuberculous Mycobacterial Vaccine, in HIV-negative and HIV-positive Adults Who Have Previously Received BCG
-
CLINICAL_TRIALS study record update · 2016-07-21Population Pharmacokinetic Analysis of Dapsone in Normal, Overweight and Obese Volunteers
-
CLINICAL_TRIALS study record update · 2016-05-13ClinicalTrials.gov study NCT00005741
-
CLINICAL_TRIALS study record update · 2016-05-13ClinicalTrials.gov study NCT00005740
-
CLINICAL_TRIALS study record update · 2016-05-12Phase I Trial to Evaluate the Safety and Immunogenicity of a ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy BCG Vaccinated Adults
-
CLINICAL_TRIALS study record update · 2016-05-12DNA Sequencing of MDR TB in Eastern Siberia
-
CLINICAL_TRIALS study record update · 2016-05-04A Phase II Double-Blind, Randomized, Placebo-controlled, Dose Escalation Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary Tuberculosis
-
CLINICAL_TRIALS study record update · 2016-04-27A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS 404 When Administered as a Single Adjuvant Amount With Different Antigen Amounts in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection
-
CLINICAL_TRIALS study record update · 2016-04-27A Phase I Randomized Placebo-controlled Double-blind Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QuantiFERON®-TB Gold (+) and QuantiFERON®-TB Gold (-) Adults Without Evidence of Tuberculosis.
-
CLINICAL_TRIALS study record update · 2016-04-20Training Inmate Peer Educators in Detecting Tuberculosis in Prisons
-
CLINICAL_TRIALS study record update · 2016-04-14A Phase III Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®-TB Gold In-Tube, in Combination With a Double Blind Randomized Split Body Safety Assessment of C-Tb Versus 2 T.U. Tuberculin PPD RT23 SSI (PPD)
-
CLINICAL_TRIALS study record update · 2016-03-16ClinicalTrials.gov study NCT00005737
-
CLINICAL_TRIALS study record update · 2016-03-08Tuberculosis in HIV-infected Patients Managed in Health Centres in Ethiopia - Identification of a Screening Algorithm for Active Tuberculosis and Determination of Outcome of Combined Antituberculosis and Antiretroviral Treatment
-
CLINICAL_TRIALS study record update · 2016-03-08Small Membrane Filtration (SMF) Method to Improve the Performance of Smear Microscopy for the Diagnosis of Pulmonary Tuberculosis in a High HIV Prevalence Setting